New cancer clinical trial: DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer

Published on: December 28, 2017 at 10:00AM
Condition:   Colorectal Neoplasm
Intervention:   Drug: DS-8201a
Sponsors:   Daiichi Sankyo Co., Ltd.;   Daiichi Sankyo, Inc.
Not yet recruiting
http://ift.tt/2BSjNsY